FDA inspection readiness focuses on preparing organizations to demonstrate regulatory compliance during FDA inspections and audits. Regulatory inspections assess not only documentation but also organizational understanding, execution, and control of regulated activities.
Inspection readiness activities typically involve evaluating regulatory documentation, submission history, and internal processes to identify potential inspection risks. Preparation includes ensuring consistency across regulatory, quality, and clinical functions.
Proactive inspection readiness reduces inspection findings, supports confident inspection responses, and minimizes operational disruption during regulatory audits.
FDA inspection readiness activities often include
- Review of regulatory records and submissions
- Assessment of regulatory governance and oversight
- Inspection risk identification and mitigation
- Preparation for investigator questions
- Support during active FDA inspections